BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31439856)

  • 1. Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease.
    Filippini D; Agosto S; Delfino P; Simbolo M; Piro G; Rusev B; Veghini L; Cantù C; Lupo F; Ugel S; De Sanctis F; Bronte V; Milella M; Tortora G; Scarpa A; Carbone C; Corbo V
    Sci Rep; 2019 Aug; 9(1):12286. PubMed ID: 31439856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.
    Elahi-Gedwillo KY; Carlson M; Zettervall J; Provenzano PP
    Cancer Res; 2019 Jan; 79(2):372-386. PubMed ID: 30401713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
    Goehrig D; Nigri J; Samain R; Wu Z; Cappello P; Gabiane G; Zhang X; Zhao Y; Kim IS; Chanal M; Curto R; Hervieu V; de La Fouchardière C; Novelli F; Milani P; Tomasini R; Bousquet C; Bertolino P; Hennino A
    Gut; 2019 Apr; 68(4):693-707. PubMed ID: 30415234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.
    Das S; Shapiro B; Vucic EA; Vogt S; Bar-Sagi D
    Cancer Res; 2020 Mar; 80(5):1088-1101. PubMed ID: 31915130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix.
    Jiang H; Torphy RJ; Steiger K; Hongo H; Ritchie AJ; Kriegsmann M; Horst D; Umetsu SE; Joseph NM; McGregor K; Pishvaian MJ; Blais EM; Lu B; Li M; Hollingsworth M; Stashko C; Volmar K; Yeh JJ; Weaver VM; Wang ZJ; Tempero MA; Weichert W; Collisson EA
    J Clin Invest; 2020 Sep; 130(9):4704-4709. PubMed ID: 32749238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization.
    Chandrakesan P; Panneerselvam J; May R; Weygant N; Qu D; Berry WR; Pitts K; Stanger BZ; Rao CV; Bronze MS; Houchen CW
    Mol Cancer Ther; 2020 Jul; 19(7):1539-1549. PubMed ID: 32371580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
    Clark CE; Hingorani SR; Mick R; Combs C; Tuveson DA; Vonderheide RH
    Cancer Res; 2007 Oct; 67(19):9518-27. PubMed ID: 17909062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.
    Wang K; Zhan Y; Huynh N; Dumesny C; Wang X; Asadi K; Herrmann D; Timpson P; Yang Y; Walsh K; Baldwin GS; Nikfarjam M; He H
    Cancer Lett; 2020 Mar; 472():8-18. PubMed ID: 31857154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Pancreatic Organoid-Derived Isografts.
    D'Agosto S; Lupo F; Corbo V
    STAR Protoc; 2020 Sep; 1(2):100047. PubMed ID: 33111093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF1R
    Candido JB; Morton JP; Bailey P; Campbell AD; Karim SA; Jamieson T; Lapienyte L; Gopinathan A; Clark W; McGhee EJ; Wang J; Escorcio-Correia M; Zollinger R; Roshani R; Drew L; Rishi L; Arkell R; Evans TRJ; Nixon C; Jodrell DI; Wilkinson RW; Biankin AV; Barry ST; Balkwill FR; Sansom OJ
    Cell Rep; 2018 May; 23(5):1448-1460. PubMed ID: 29719257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
    Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
    Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.
    Bayne LJ; Beatty GL; Jhala N; Clark CE; Rhim AD; Stanger BZ; Vonderheide RH
    Cancer Cell; 2012 Jun; 21(6):822-35. PubMed ID: 22698406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.
    Stromnes IM; Brockenbrough JS; Izeradjene K; Carlson MA; Cuevas C; Simmons RM; Greenberg PD; Hingorani SR
    Gut; 2014 Nov; 63(11):1769-81. PubMed ID: 24555999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer.
    Imai D; Yoshizumi T; Okano S; Itoh S; Ikegami T; Harada N; Aishima S; Oda Y; Maehara Y
    J Surg Res; 2019 Aug; 240():115-123. PubMed ID: 30927618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells.
    Manzo T; Prentice BM; Anderson KG; Raman A; Schalck A; Codreanu GS; Nava Lauson CB; Tiberti S; Raimondi A; Jones MA; Reyzer M; Bates BM; Spraggins JM; Patterson NH; McLean JA; Rai K; Tacchetti C; Tucci S; Wargo JA; Rodighiero S; Clise-Dwyer K; Sherrod SD; Kim M; Navin NE; Caprioli RM; Greenberg PD; Draetta G; Nezi L
    J Exp Med; 2020 Aug; 217(8):. PubMed ID: 32491160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
    Bishehsari F; Zhang L; Barlass U; Preite NZ; Turturro S; Najor MS; Shetuni BB; Zayas JP; Mahdavinia M; Abukhdeir AM; Keshavarzian A
    Int J Cancer; 2018 Oct; 143(8):1994-2007. PubMed ID: 29756386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
    Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
    Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen.
    Ogawa Y; Masugi Y; Abe T; Yamazaki K; Ueno A; Fujii-Nishimura Y; Hori S; Yagi H; Abe Y; Kitago M; Sakamoto M
    Clin Cancer Res; 2021 Jan; 27(1):107-119. PubMed ID: 33046515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.